芪龙糖肾汤治疗糖尿病肾病的临床观察  

Clinical Observation on Qilong Tangshen Decoction in Treating Diabetic Nephropathy

作　　者：申林[1] 

机构地区：[1]沈阳市中医院肾病科,辽宁沈阳110003

出　　处：《中国中医药现代远程教育》2017年第19期62-63,68,共3页Chinese Medicine Modern Distance Education of China

摘　　要：目的观察芪龙糖肾汤应用于中期糖尿病肾病患者临床治疗中的效果。方法选取2015年3月—2017年3月在沈阳市中医院肾病科门诊及病房收治的中期糖尿病肾病患者132例,随机分为对照组及治疗组各66例,分别给予西药ACEI/ARB类口服和加用芪龙糖肾汤治疗。结果尿微量白蛋白、24 h尿蛋白定量、空腹血糖、餐后2 h血糖、血浆总胆固醇、甘油三酯等相关指标,治疗组患者均明显优于对照组(P<0.05);治疗总有效率,治疗组明显高于对照组(P<0.05)。结论芪龙糖肾汤应用于中期糖尿病肾病患者临床治疗的效果十分理想,值得临床推广运用。Objective To observe the clinical effect of Qilong Tangshen decoction in treating the early and middle stage diabetic nephropathy. Methods 132 patients with diabetic nephropathy from March 2015 to March 2017 in the nephropathy department of Shenyang hospital of traditional Chinese medicine were chosen for this study. These patients were randomly divided into the control group of 66 cases and the treatment group of 66 cases in order to compare the treatment effect from medicine containing ACEI/ARB and Qilong Tangshen decoction. Results In terms of the level of urine microalbumin, 24-hour urinary protein, fasting blood-glucose（FBG）, 2-hour postprandial blood glucose（PBG）, serum total cholesterol and triglyceride, the clinical effect of the treatment group were dramatically better than the other group. The total effective rate of the treatment group（92.42 %） was obviously higher than that of the control group（ 72.73%）. Comparing with the control group（ P〈0.05）, these comparative data had statistical significance. Conclusion Qilong Tangshen decoction in the treatment of the early and middle stage diabetic nephropathy has salient effect, and is worth popularizing in the clinical treatment.

关 键 词：芪龙糖肾汤 糖尿病 肾病 消渴 水肿 

分 类 号：R277.5[医药卫生—中医学]